COVID turned SmartBarrel's shared time clocks into a health risk overnight. Albert Bou Fadel had six weeks to reinvent the product or lose the company.
Mid-way through an eight-million-dollar trial, Yi-Kai Lo found a defect that made the treatment useless. He shut down enrollment across all fourteen sites.
